TFCP2L1-IN-1, CAS 364621-46-5

Product Description: TFCP2L1-IN-1 is a specific small molecule targeting TFCP2L1’s active domain with anti-cancer activity. TFCP2L1-IN-1 synergizes with Sorafenib (HY-10201) to induce Apoptosis and reduces cell proliferation, invasion, metastasis, clonal formation and sphere-forming capacity in hepatocellular carcinoma cells[1].

Applications: Cancer-programmed cell death

Formula: C15H13BrN2OS

References: [1]Qiu D, et al. TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma. Oncogenesis. 2024 Sep 12;13(1):33.

CAS Number: 364621-46-5

Molecular Weight: 349.25

Compound Purity: 99.66

Research Area: Cancer

Solubility: DMSO : 175 mg/mL (ultrasonic)

Target: Apoptosis

• Artikelnummer: MEXHY-162934-100
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-162934-100
• Verpackungseinheit: 100 mg
• Mengeneinheit: STK